Trials / Completed
CompletedNCT06640504
Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
Serum Albumin Ratios Correct the Ability of Traditional Biomarkers to Predict Mortality of Sepsis Patients Admitted to Surgical ICU
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Sepsis remains a leading cause of mortality in hospitalized patients, despite advancements in critical care. Existing clinical scores for predicting sepsis outcomes often lack generalizability and complexity, hindering accurate risk assessment and timely intervention. This study aimed to evaluate the prognostic performance of serum albumin ratios to C-reactive protein (CRP), procalcitonin (PCT), and lactate in predicting 28-day morbidities and mortality in sepsis patients admitted to surgical ICUs. By incorporating these albumin ratios into clinical decision-making, we hypothesized that clinicians could more accurately identify patients at high risk of adverse outcomes and tailor treatment strategies accordingly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | serum albumin | Serum albumin ratios were calculated as the ratio between the estimated blood lactate, and serum levels of CRP and PCT divided by the estimated serum albumin level to get the lactate-to-albumin ratio (LAR), CRP-to-albumin ratio (CAR) and procalcitonin (PCT)-to-albumin ratio (PAR). |
| DIAGNOSTIC_TEST | C-Reactive Protein | The serum levels of C-reactive protein (CRP) are divided by the estimated serum albumin level to get the CRP-to-albumin ratio (CAR). |
| DIAGNOSTIC_TEST | Serum procalcitonin | The serum levels of procalcitonin (PCT) are divided by the estimated serum albumin level to get the PCT-to-albumin ratio (PAR). |
| DRUG | Blood Lactate | The serum levels of blood lactate are divided by the estimated serum albumin level to get the lactate-to-albumin ratio (LAR). |
Timeline
- Start date
- 2024-09-30
- Primary completion
- 2024-11-30
- Completion
- 2024-12-30
- First posted
- 2024-10-15
- Last updated
- 2025-11-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06640504. Inclusion in this directory is not an endorsement.